Joerg Rosenberg,Matthias Degenhardt,Joerg Breitenbach,Tom L. Reiland,Kennan C. Marsh
申请号：
US13421420
公开号：
US20120178808A1
申请日:
2012.03.15
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A formulation comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients is described. Fenofibric acid, the physiologically acceptable salt or derivative thereof is preferably in the form of a molecular dispersion in these formulations. An advantageous process for their preparation, in particular by melt extrusion, and the use of this formulation for oral administration of fenofibric acid, a physiologically acceptable salt or derivative thereof are likewise described.
